Medical robotics company Medrobotics has obtained CE Mark approval for its Flex system, a robot-assisted flexible endoscopic platform for use in surgical procedures.

The Flex System is anticipated to provide a cost-effective, robot-assisted surgical platform for hospitals and surgeons eager to expand their offering of minimally-invasive treatment options to the broadest number of patients.

According to Medrobotics, the Flex System enables physicians to navigate the Flex endoscope around anatomical structures to hard-to-reach locations through a single access site, and then use the onboard high-definition vision system to precisely deploy a range of third party flexible surgical instruments.

The wristed 3mm Flex Instruments enable the surgeon to operate in confined spaces, further extending the reach to important and often challenging areas of the anatomy.

Medrobotics president and CEO Dr Samuel Straface noted the Flex system is the first robot-assisted flexible endoscopic platform for use during surgical procedures.

"The system enables surgeons to access and visualize hard-to-reach anatomical locations and deploy specially designed flexible surgical instruments to perform procedures," Dr Straface added.

With the CE Mark approval, the company will initiate a limited commercial launch of the product in select European markets. The company prepares for European commercialization of the Flex system in otolaryngology.